Lisa Barrow-Laing, Ph.D., Pmp Email & Phone Number

Leverkusen, North Rhine-Westphalia, De

Leverkusen, North Rhine-Westphalia, De

Venlo, Limburg, Nl

Venlo, Limburg, Nl

In this role I serve as a scientific and technical customer liaison responsible for supporting the Commercial Operations organization in the strategic placement of digital bioinformatics solutions used in clinical decision support and for clinical market growth and adoption. I also served as a global product management co-lead on new software product development efforts and supporting customers and cross-business leaders on clinical informatics solutions.Select accomplishments include:➠ Spearheaded and worked with Sales, Busienss administration, Marketing, Customer Support, Engineering, R&D, and global Field Application Scientist teams on multiple pre-sales, implementation, and post-sales support projects. ➠ Received the 2020 QIAGEN Digital Insights Sales Achievement Award. Recogized as a top performer and producer every year.➠ Promoted brand awareness across academic and commercial sectors by fostering relationships with oncology and hereditary disorder field KOLs.➠ Delivered workshops, trainings, and product demonstrations to oncologists, molecular pathologists, genetic counselors, variant scientists and laboratory directors.

San Diego, Ca, Us

In this role I was selected as the primary Illumina representative, liaison, and communicator to molecular tumor board where I provided insight on cancer patient treatment options to healthcare providers to identify and match oncology drugs within the American Society of Clinical Oncology TAPUR clinical trial.Another element of the role was providing external cancer centers, globally recognized organizations, and internal stakeholders with product demonstrations on genomic variant interpretation platforms, earning the distinction as the subject matter expert called upon to provide critical data, insights, and knowledge.Selected highlights include:➠ Successful execution of high-visibility projects, including the Genomics England 100,000 Genomes Project and the ASCO TAPUR clinical trial.➠ Curated and orchestrated the sharing of oncology datasets with Clinical Interpretations of Variants in Cancer (CIViC).➠ Performed variant interpretation platform demonstrations for renowned cancer centers and organizations, stakeholders, and cancer centers.➠ Conducted extensive clinical curation for the Illumina Clinical Laboratory Services and the Illumina Base Space Variant Interpreter (tertiary analysis software).➠ Built partnerships with selected companies that support the informatics business area in next-generation sequencing testing.

Lexington, Ma, Us

In this position, I analyzed clinical and scientific data, performed targeted searches, and identified clinically literature to produce client diagnostic and treatment strategies for cancer patients. I utilized various bioinformatics databases and tools to annotate and curate information on specific cancer types and genetic variants and hone oncology knowledge.Notable highlights:➠ Annotated and curated a wide range of data across various bioinformatics databases and tools on specific cancer types and genetic variants.➠ Delivered presentations on precision medicine and cancer genomics at the Center for Pharmacogenomics and individualized therapy at the University of North Carolina (2014).➠ Completed hundreds of clinical reports used to support decisions on how cancer patients should be treated.

Us

➠ Determined the mechanism of pRB degradation by high-risk human papillomavirus (HPV) E7 proteins and delineated the individual components that are involved.➠ Perturbed the proteasome-ubiquitin pathway with small molecule inhibitors to gain insight into how individual HPV proteins contribute to carcinogenesis.

Indianapolis, In, Us

➠ Determined the cellular localization and half-life of p130 in HPV 6 E7 and HPV 16 E7expressing human foreskin keratinocytes by immunofluorescence and sub-cellularfractionation.➠ Validated the binding of potential binding partners to HPV E7 by co-immunoprecipitations and GST pull-down assays and explored the effect of these HPV-E7 binding partners on HPV E7-mediated p130 degradation using siRNA techniques.

Columbia, Sc, Us

➠ Investigated the effect of human papillomavirus E6 on mRNA levels associated withepidermal growth factor receptor and the effect of p53 siRNA on the epidermalgrowth factor receptor promoter.

University Park, Pa, Us

➠ Assessed the effect of glucocorticoids on the upstream regulatory region of HPV type18.

Columbia, Sc, Us

Education record

Ph.D., Microbiology And Immunology

Bachelor'S Of Science, Summa Cum Laude, Biology, General